PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4400
-0.0100 (-2.22%)
At close: Feb 4, 2026
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 73.45 million as of February 5, 2026. Its market cap has increased by 18.15% in one year.
Market Cap
73.45M
Enterprise Value
72.98M
Revenue
17.60M
Ranking
n/a
PE Ratio
272.45
Stock Price
0.44
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 73.45M, an increase of 2,960.32%. That is a compound annual growth rate of 177.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 75.12M | -1.10% |
| Dec 31, 2025 | 75.95M | 19.91% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.30B |
| Extendicare | 2.26B |
| Sienna Senior Living | 2.16B |
| Green Thumb Industries | 2.11B |
| Planet 13 Holdings | 77.12M |
| Medicenna Therapeutics | 75.08M |
| BioNxt Solutions | 73.49M |
| Vext Science | 72.80M |